|
|
 |
 |
| |
 |
| |
- "Effects of A Dietary Supplement, OLIVENOL™, on Disease Activity in Patients with Osteoarthritis and Rheumatoid Arthritis" Matt, Arizona State University, Tempe.
- "Evaluation of Skin Conditions in Humans Following OLIVENOL™ Consumption", Numano, Tokyo Vascular Disease Institute, Japan.
- "Study of the ORAC Levels in Plasma of Healthy Adult Human Subjects after Consumption of OLIVENOL™, Spiller, Health Research and Study Centre (HRSC), Los Altos, California.
- "Determination of GRAS Status of Hydrolyzed Aqueous Olive Pulp Extract (HIDROX) Used As An Antioxidant or Antimicrobial Agent", Borzelleca, Burdock Group Technology and Risk Assessment, Jun 15, 2004.
- "Assessing the Antioxidant Potential of OLIVENOL™ In an In Vitro Model of Neuroinflammation in Parkinson’s Disease", Bolin, CreAgri Project, June 25, 2003.
- "Effects of OLIVENOL™ on Patients with Hyperlipidemia", Numano, Tokyo Vascular Disease Institute, Japan.
- "Olive extract supplement decreases pain and improves activities of daily living in human beings with osteoarthritis and decreases plasma homocysteine in human beings with rheumatoid arthritis", Crea, Elsevier Inc.
- "Effect of OLIVENOL™ (Polyphenols Hydroxytyrosol-Rich) in Normal Rats", Iacoviello, Laboratory of Genetic and Environmental, Vascular Risk Factors, November 2002.
- "Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods", Crea, Elsevier Ltd, January 14, 2006.
- "The Toxicity Profile of Hydrolyzed Aqueous Olive Pulp Extract", Crea Drug and Chemical Toxicology Vol 27, No.4, pp 309-330, 2004.
- "Protection against ultraviolet radiation-induced cutaneous inflammation with OLIVENOL™ in hairless mice", Crea, CreAgri, Inc.
- "Water-soluble polyphenols from pulp of olives (OLIVENOL™) suppressed endothelial cell injury induced by 15-hydroperoxyeicosatetraenioic acid", Onodera, American Society for Cell Biology, December 2003.
- "Hydrolyzed Olive Vegetation Water in Mice has Anti-inflammatory Activity" Crea, American Society for Nutritional Sciences, March 21, 2005.
- "A Study of Approximately 5 weeks to Evaluate Cutaneous and General Toxicity of Orally or Topically Administered OLIVENOL™ in CRL:SKH1-hrBR Hairless Mice", Argus Research Laboratories, Inc.
|
 |
|
|
|
